Principal investigators recognize the need for greater diversity among participants in the clinical trials they run but are frustrated that the inclusion/exclusion criteria handed to them by sponsors often don't match the real-life situations of the average patient in their practice with the condition of...
In their combined feedback to the FDA, ACRP members and volunteers weighed in on a variety of concerns they had over vague language and possible misconceptions about DCTs in the draft guidance....
Following the release of some initial reactions to the draft guidance in May, volunteer members of ACRP’s DCT Think Tank Regulatory Working Group and other subject matter experts, including the ACRP Content Committee and ACRP Fellows, took a closer look at how FDA worded its...
Clinical trial recruitment and retention could be boosted by physicians integrating clinical trials into their private community practices to make clinical research a natural extension of the routine care they provide their patients....
A knowledgeable and compassionate team of nurses helps cancer patients at the UW Health | Carbone Cancer Center learn about and connect to clinical trials that may provide another avenue for treatment....
The agency proposes significant revisions to oversight programs for drugs and medical products....
More restrictive LGBTQ+ bills are being passed in the US that might negatively impact transgender individuals in clinical trials....
UW Health is recruiting volunteers for a clinical trial to test a new Alzheimer's drug recently approved by the FDA....
The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease....
The U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs for potential treatment of medical conditions, including psychiatric or substance use disorders....
